Paper7986589
High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection.
Daniel MD and 6 others. AIDS Res Hum Retroviruses, 1994. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. Papers, record 7986589. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7986589
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| SAIDS Vaccines | Major topic |
| Simian Acquired Immunodeficiency Syndrome | Major topic |
| Simian Immunodeficiency Virus | Major topic |
| Animals | |
| Antibody Formation | |
| Blotting, Western | |
| CD4-Positive T-Lymphocytes | |
| Immunization, Secondary | |
| Macaca mulatta | |
| Trachea | |
| Vaccination | |
| Virulence |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI26507 | NIAID NIH HHS | United States | PubMed | PubMed | |
| RR00168 | NCRR NIH HHS | United States | P06RR000168 | PubMed and NIH | NIH RePORTER |
| P40RR000168 | NIH | NIH RePORTER | |||
| P51RR000168 | NIH | NIH RePORTER |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17580087 | A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. | Virology | 2007 | https://conductscience.org/library/papers/17580087 | PubMed |
| 16306607 | A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease. | J Virol | 2005 | https://conductscience.org/library/papers/16306607 | PubMed |
| 15975024 | Non-human primate models for AIDS vaccine research. | Curr Drug Targets Infect Disord | 2005 | https://conductscience.org/library/papers/15975024 | PubMed |
| 11462016 | Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. | J Virol | 2001 | https://conductscience.org/library/papers/11462016 | PubMed |
| 10482571 | Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. | J Virol | 1999 | https://conductscience.org/library/papers/10482571 | PubMed |
| 10233957 | Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. | J Virol | 1999 | https://conductscience.org/library/papers/10233957 | PubMed |
| 9847367 | Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. | J Virol | 1999 | https://conductscience.org/library/papers/9847367 | PubMed |
| 9811759 | Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. | J Virol | 1998 | https://conductscience.org/library/papers/9811759 | PubMed |
| 9658099 | Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. | J Virol | 1998 | https://conductscience.org/library/papers/9658099 | PubMed |
| 9557706 | Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure. | J Virol | 1998 | https://conductscience.org/library/papers/9557706 | PubMed |
| 9499101 | Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus. | J Virol | 1998 | https://conductscience.org/library/papers/9499101 | PubMed |
| 9445059 | Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. | J Virol | 1998 | https://conductscience.org/library/papers/9445059 | PubMed |
| 9445045 | Identification of highly attenuated mutants of simian immunodeficiency virus. | J Virol | 1998 | https://conductscience.org/library/papers/9445045 | PubMed |
| 9343164 | Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. | J Virol | 1997 | https://conductscience.org/library/papers/9343164 | PubMed |
| 8986737 | Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. | Nat Med | 1997 | https://conductscience.org/library/papers/8986737 | PubMed |
| 8648735 | Simian immunodeficiency virus DNA vaccine trial in macaques. | J Virol | 1996 | https://conductscience.org/library/papers/8648735 | PubMed |
| 8627721 | Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. | J Virol | 1996 | https://conductscience.org/library/papers/8627721 | PubMed |
| 8523593 | Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. | J Virol | 1996 | https://conductscience.org/library/papers/8523593 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7986589
GET https://conductscience.org/api/papers/v1/7986589/authors